Anti-ERBB2 (Trastuzumab)-hydroxyl amino PEG linker-MMAD (monomethyl auristatin D) ADC
CAT:
708-ADC-W-413
Size:
1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Anti-ERBB2 (Trastuzumab)-hydroxyl amino PEG linker-MMAD (monomethyl auristatin D) ADC
- Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a hydroxyl amino PEG linker to a MMAD. The MMAD is targeted to breast cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAD binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- CAS Number: 9007-83-4
- Format: Solution
- Shipping Conditions: Ice Packs
- Storage Conditions: -20°C